<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31817338</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Existing and Emerging Metabolomic Tools for ALS Research.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1011</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes10121011</ELocationID><Abstract><AbstractText>Growing evidence suggests that aberrant energy metabolism could play an important role in the pathogenesis of amyotrophic lateral sclerosis (ALS). Despite this, studies applying advanced technologies to investigate energy metabolism in ALS remain scarce. The rapidly growing field of metabolomics offers exciting new possibilities for ALS research. Here, we review existing and emerging metabolomic tools that could be used to further investigate the role of metabolism in ALS. A better understanding of the metabolic state of motor neurons and their surrounding cells could hopefully result in novel therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Germeys</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandoorne</LastName><ForeName>Tijs</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2431-7785</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bercier</LastName><ForeName>Val&#xe9;rie</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2672-7705</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">energy metabolism</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">metabolic dysfunction</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31817338</ArticleId><ArticleId IdType="pmc">PMC6947647</ArticleId><ArticleId IdType="doi">10.3390/genes10121011</ArticleId><ArticleId IdType="pii">genes10121011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Robert H., Brown D.W.C., Jr. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., Van Zee J.D. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., De Bock K., Van Den Bosch L. Energy metabolism in ALS: An underappreciated opportunity? Acta Neuropathol. 2018;135:489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J.J., Jolivet R., Attwell D. Synaptic Energy Use and Supply. Neuron. 2012;75:762&#x2013;777. doi: 10.1016/j.neuron.2012.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.08.019</ArticleId><ArticleId IdType="pubmed">22958818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Z.H. The Interplay of Axonal Energy Homeostasis and Mitochondrial Trafficking and Anchoring. Trends Cell Biol. 2017;27:403&#x2013;416. doi: 10.1016/j.tcb.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2017.01.005</ArticleId><ArticleId IdType="pmc">PMC5440189</ArticleId><ArticleId IdType="pubmed">28228333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti P.J., Allaman I. A Cellular Perspective on Brain Energy Metabolism and Functional Imaging. Neuron. 2015;86:883&#x2013;901. doi: 10.1016/j.neuron.2015.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.035</ArticleId><ArticleId IdType="pubmed">25996133</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T., Veys K., Guo W., Sicart A., Vints K., Swijsen A., Moisse M., Eelen G., Gounko N., Fumagalli L., et al. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat. Commun. 2019;10:4147. doi: 10.1038/s41467-019-12099-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12099-4</ArticleId><ArticleId IdType="pmc">PMC6742665</ArticleId><ArticleId IdType="pubmed">31515480</ArticleId></ArticleIdList></Reference><Reference><Citation>Divakaruni A.S., Wallace M., Buren C., Martyniuk K., Andreyev A.Y., Li E., Fields J.A., Cordes T., Reynolds I.J., Bloodgood B.L., et al. Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. J. Cell Biol. 2017;216:1091&#x2013;1105. doi: 10.1083/jcb.201612067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201612067</ArticleId><ArticleId IdType="pmc">PMC5379957</ArticleId><ArticleId IdType="pubmed">28254829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendt S.-M., Verstreken P. Neurons eat glutamate to stay alive. J. Cell Biol. 2017;216:863&#x2013;865. doi: 10.1083/jcb.201702003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201702003</ArticleId><ArticleId IdType="pmc">PMC5379959</ArticleId><ArticleId IdType="pubmed">28298409</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter D.G., Avignon D.A., Wentz A.E., Weber M.L., Crawford P.A. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J. Biol. Chem. 2011;286:6902&#x2013;6910. doi: 10.1074/jbc.M110.192369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.192369</ArticleId><ArticleId IdType="pmc">PMC3044945</ArticleId><ArticleId IdType="pubmed">21209089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamanna J.C., Salem N., Puchowicz M., Erokwu B., Flask C., Lee Z. Ketonedssuppress brain glucose consumption. Adv. Exp. Med. Biol. 2010;645:301&#x2013;306. doi: 10.1007/978-0-387-85998-9_45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-85998-9_45</ArticleId><ArticleId IdType="pmc">PMC2874681</ArticleId><ArticleId IdType="pubmed">19227486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarlone S.L., Grieco J.C., Agostino D.P.D., Weeber E.J. Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model. Neurobiol. Dis. 2016;96:38&#x2013;46. doi: 10.1016/j.nbd.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.002</ArticleId><ArticleId IdType="pubmed">27546058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouzier-Sore A.K., Voisin P., Bouchaud V., Bezancon E., Franconi J.M., Pellerin L. Competition between glucose and lactate as oxidative energy substrates in both neurons and astrocytes: A comparative NMR study. Eur. J. Neurosci. 2006;24:1687&#x2013;1694. doi: 10.1111/j.1460-9568.2006.05056.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.05056.x</ArticleId><ArticleId IdType="pubmed">17004932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O&#x2019;Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N., et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci. 2014;34:11929&#x2013;11947. doi: 10.1523/JNEUROSCI.1860-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1860-14.2014</ArticleId><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Irish M., Piguet O., Halliday G.M., Ittner L.M., Farooqi S., Hodges J.R., Kiernan M.C. Amyotrophic lateral sclerosis and frontotemporal dementia: Distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332&#x2013;342. doi: 10.1016/S1474-4422(15)00380-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., van Eijk R.P.A., Chachay V., van den Berg L.H., McCombe P.A., Henderson R.D., Steyn F.J. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2019;20:497&#x2013;505. doi: 10.1080/21678421.2019.1621346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621346</ArticleId><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Ioannides Z.A., Van Eijk R.P.A., Heggie S., Thorpe K.A., Ceslis A., Heshmat A., Henders A.K., Wray N.R., Van Den Berg L.H., et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C., Higgins C.M.J., Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J. Neurochem. 2002;83:535&#x2013;545. doi: 10.1046/j.1471-4159.2002.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01112.x</ArticleId><ArticleId IdType="pubmed">12390515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Flint Beal M., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelechowski M., Amoedo N., Obre E., L&#xe9;ger C., Allard L., Bonneu M., Claverol S., Lacombe D., Oliet S., Chevallier S., et al. Metabolic Reprogramming in Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:3953. doi: 10.1038/s41598-018-22318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22318-5</ArticleId><ArticleId IdType="pmc">PMC5834494</ArticleId><ArticleId IdType="pubmed">29500423</ArticleId></ArticleIdList></Reference><Reference><Citation>So E., Mitchell J.C., Memmi C., Chennell G., Vizcay-Barrena G., Allison L., Shaw C.E., Vance C. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUS WT transgenic mice. Hum. Mol. Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., Wainger B.J., Han S., Peng T., Thams S., Mikkilineni S., et al. Pathways Disrupted in Human ALS Motor Neurons Identified Through Genetic Correction of Mutant SOD1. Cell Stem. Cell. 2014;14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Sagua R., Parra V., L&#xf3;pez-Crisosto C., D&#xed;az P., Quest A., Lavandero S. Calcium Transport and Signaling in Mitochondria. Compr. Physiol. 2017;7:623&#x2013;634. doi: 10.1002/cphy.c160013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c160013</ArticleId><ArticleId IdType="pubmed">28333383</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikl&#xf3;s L., Engelhardt J., Harati Y., Smith R.G., Jo&#xf3; F., Appel S.H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 1996;39:203&#x2013;216. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordov&#xe1;s L., Patel A., Welters M., Vanwelden T., et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautenschl&#xe4;ger J., Prell T., Ruhmer J., Weidemann L., Witte O.W., Grosskreutz J. Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons. Exp. Neurol. 2013;247:91&#x2013;100. doi: 10.1016/j.expneurol.2013.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.03.027</ArticleId><ArticleId IdType="pubmed">23578819</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Iwata M. Ultrastructural study of the synapses of central chromatolytic anterior horn cells in motor neuron disease. J. Neuropathol. Exp. Neurol. 1996;55:932&#x2013;939. doi: 10.1097/00005072-199608000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199608000-00009</ArticleId><ArticleId IdType="pubmed">8759783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Flint Beal M., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Chiang P.-M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. USA. 2010;107:16325&#x2013;16330. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Xu Z. Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1. J. Neurosci. 2018;18:3241&#x2013;3250. doi: 10.1523/JNEUROSCI.18-09-03241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.R. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 1999;46:787&#x2013;790. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas M., Hatazawa J., Brooks R., Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann. Neurol. 1987;22:580&#x2013;586. doi: 10.1002/ana.410220504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410220504</ArticleId><ArticleId IdType="pubmed">3501273</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M., Fania P., Cistaro A. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83:1067&#x2013;1074. doi: 10.1212/WNL.0000000000000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000792</ArticleId><ArticleId IdType="pubmed">25122207</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini C., Morbelli S., Cistaro A., Campi C., Caponnetto C., Bauckneht M., Bellini A., Buschiazzo A., Calamia I., Beltrametti M.C., et al. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis. Brain. 2018;141:2272&#x2013;2279. doi: 10.1093/brain/awy152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy152</ArticleId><ArticleId IdType="pmc">PMC6061793</ArticleId><ArticleId IdType="pubmed">30730551</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Laere K., Vanhee A., Verschueren J., De Coster L., Driesen A., Dupont P., Robberecht W., Van Damme P. Value of 18 Fluorodeoxyglucose&#x2013;Positron-Emission Tomography in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2014;71:553. doi: 10.1001/jamaneurol.2014.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.62</ArticleId><ArticleId IdType="pubmed">24615479</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Masamoto K., Morimoto N., Kurata T., Mimoto T., Obata T., Kanno I., Abe K. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J. Cereb. Blood Flow Metab. 2012;32:456&#x2013;467. doi: 10.1038/jcbfm.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.155</ArticleId><ArticleId IdType="pmc">PMC3293114</ArticleId><ArticleId IdType="pubmed">22068226</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R., Allen S.P., Goodall E.F., Kramer S., Ponger L.L., Heath P.R., Milo M., Hollinger H.C., Walsh T., Highley J.R., et al. Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.S., Simmons Z., Liu W., Boyer P.J., Connor C.J. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotropic Lateral Scler. 2006;7:201&#x2013;210. doi: 10.1080/17482960600947689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600947689</ArticleId><ArticleId IdType="pubmed">17127558</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A.-L., Zoll J., Echaniz-Laguna A., Loeffler J.-P., et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis. Neurosci. Lett. 1999;260:204&#x2013;206. doi: 10.1016/S0304-3940(98)00986-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(98)00986-0</ArticleId><ArticleId IdType="pubmed">10076903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M., Brown R.H., Matson W., Smart R., Hayden D., O&#x2019;Donnell H., Flint Beal M., Cudkowicz M. Increased oxidative damage to DNA in ALS patients. Free Radic Biol. Med. 2000;29:652&#x2013;658. doi: 10.1016/S0891-5849(00)00349-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Santella R., Liu X., Bogdanov M., Zipprich J., Wu H.C., Mahata J., Kilty M., Bednarz K., Bell D., et al. Oxidative stress biomarkers in sporadic ALS. Amyotroph Lateral Scler. 2008;9:177&#x2013;183. doi: 10.1080/17482960801933942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801933942</ArticleId><ArticleId IdType="pmc">PMC4332387</ArticleId><ArticleId IdType="pubmed">18574762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A., Oudart H., De Aguilar J.L.G., Fricker B., Ren&#xe9; F., Hocquette J.F., Meininger V., Dupuis L., Loeffler J.P. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 2007;48:1571&#x2013;1580. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge J.C., Treleaven C.M., Fidler J.A., Tamsett T.J., Bao C., Searles M., Taksir T.V., Misra K., Sidman R.L., Cheng S.H., et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:10812&#x2013;10817. doi: 10.1073/pnas.1308421110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308421110</ArticleId><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Corcia P., Moreau C., Veau S., Fournier C., Vourc&#x2019;h P. 1H-NMR-Based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e13223. doi: 10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593</ArticleId><ArticleId IdType="pmc">PMC2951909</ArticleId><ArticleId IdType="pubmed">20949041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Bala L., Kalita J., Misra U.K., Singh R.L., Khetrapal C.L., Babu G.N. Metabolomic analysis of serum by (1)H NMR spectroscopy in amyotrophic lateral sclerosis. Clin. Chim. Acta. 2010;411:563&#x2013;567. doi: 10.1016/j.cca.2010.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.01.016</ArticleId><ArticleId IdType="pubmed">20096678</ArticleId></ArticleIdList></Reference><Reference><Citation>Barroso E., Rodr&#xed;guez-Calvo R., Serrano-Marco L., Astudillo A.M., Balsinde J., Palomer X., V&#xe1;zquez-Carrera M. The PPAR&#x3b2;/&#x3b4; activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1&#x3b1;-lipin 1-PPAR&#x3b1; pathway leading to increased fatty acid oxidation. Endocrinology. 2011;152:1848&#x2013;1859. doi: 10.1210/en.2010-1468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2010-1468</ArticleId><ArticleId IdType="pubmed">21363937</ArticleId></ArticleIdList></Reference><Reference><Citation>Thau N., Knippenberg S., K&#xf6;rner S., Rath K.J., Dengler R., Petri S. Decreased mRNA expression of PGC-1&#x3b1; and PGC-1&#x3b1;regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 2012;71:1064&#x2013;1074. doi: 10.1097/NEN.0b013e318275df4b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318275df4b</ArticleId><ArticleId IdType="pubmed">23147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 1999;40:1549&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">10484602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Dubourg O., De Tapia M., Di Scala F., Dupuis L., Lenglet T., Bruneteau G., Salachas F., Lacomblez L., Corvol J.C., et al. Muscle gene expression is a marker of amyotrophic lateral sclerosis severity. Neurodegener. Dis. 2011;9:38&#x2013;52. doi: 10.1159/000329723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000329723</ArticleId><ArticleId IdType="pubmed">21934272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain G., Schmitt F., Henriques A., Lequeu T., Rene F., Bindler F., Dirrig-Grosch S., Oudart H., Palamiuc L., Metz-Boutigue M.H., et al. Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0064525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064525</ArticleId><ArticleId IdType="pmc">PMC3681796</ArticleId><ArticleId IdType="pubmed">23785402</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A., Nativio R., Berger S.L., Bonini N.M. Epigenetic Regulation in Neurodegenerative Diseases. Trends Neurosci. 2018;41:587&#x2013;598. doi: 10.1016/j.tins.2018.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC6174532</ArticleId><ArticleId IdType="pubmed">29885742</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonnell E., Crown S.B., Fox D.B., Kitir B., Ilkayeva O.R., Olsen C.A., Grimsrud P.A., Hirschey M.D. Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation. Cell Rep. 2016;17:1463&#x2013;1472. doi: 10.1016/j.celrep.2016.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.10.012</ArticleId><ArticleId IdType="pmc">PMC5123807</ArticleId><ArticleId IdType="pubmed">27806287</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdieri L., Vancura A. Acetyl-CoA carboxylase regulates global histone acetylation. J. Biol. Chem. 2012;287:23865&#x2013;23876. doi: 10.1074/jbc.M112.380519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.380519</ArticleId><ArticleId IdType="pmc">PMC3390662</ArticleId><ArticleId IdType="pubmed">22580297</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen C., Schmalbach S., Boeselt S., Sarlette A., Dengler R., Petri S. Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2010;69:573&#x2013;581. doi: 10.1097/NEN.0b013e3181ddd404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ddd404</ArticleId><ArticleId IdType="pubmed">20467334</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sendscheid O., El Oussini H., Jambeau M., Sun Y., Mersmann S., Wagner M., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S., et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle C., Salvatori I., Gerbino V., Rossi S., Palamiuc L., Ren&#xe9; F., Carr&#xec; M.T. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: Pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis. 2014;5 doi: 10.1038/cddis.2014.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.247</ArticleId><ArticleId IdType="pmc">PMC4611720</ArticleId><ArticleId IdType="pubmed">24946089</ArticleId></ArticleIdList></Reference><Reference><Citation>Alao J.P. The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol. Cancer. 2007;6:24. doi: 10.1186/1476-4598-6-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-6-24</ArticleId><ArticleId IdType="pmc">PMC1851974</ArticleId><ArticleId IdType="pubmed">17407548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert E., Pollari E., Jaspers T., Van Helleputte L., Jarpe M., Van Damme P., De Bock K., Moisse M., Van Den Bosch L. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol. Commun. 2019;7:107. doi: 10.1186/s40478-019-0750-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pmc">PMC6612190</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P., Blacher E., Elinav E., Pettersson S. Our Gut Microbiome: The Evolving Inner Self. Cell. 2017;171:1481&#x2013;1493. doi: 10.1016/j.cell.2017.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.024</ArticleId><ArticleId IdType="pubmed">29245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yi J., Zhang Y.G., Zhou J., Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 2015;3 doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wu S., Yi J., Xia Y., Jin D., Zhou J., Sun J. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clin. Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Wang X., Yang S., Meng F., Wang X., Wei H., Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front. Microbiol. 2016;7:1479. doi: 10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E., Bashiardes S., Shapiro H., Rothschild D., Mor U., Dori-Bachash M., Kleimeyer C., Moresi C., Harnik Y., Zur M., et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Supandi F., van Beek J.H.G.M. Computational prediction of changes in brain metabolic fluxes during Parkinson&#x2019;s disease from mRNA expression. PLoS ONE. 2018;13 doi: 10.1371/journal.pone.0203687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0203687</ArticleId><ArticleId IdType="pmc">PMC6135490</ArticleId><ArticleId IdType="pubmed">30208076</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies K.J., Zhang H., Katsyuba E., Auwerx J. Protein acetylation in metabolism-metabolites and cofactors. Nat. Rev. Endocrinol. 2016;12:43&#x2013;60. doi: 10.1038/nrendo.2015.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2015.181</ArticleId><ArticleId IdType="pubmed">26503676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls D.G., Darley-usmar V.M., Wu M., Jensen P.B., Rogers G.W., Ferrick D.A. Bioenergetic Profile Experiment using C2C12 Myoblast Cells. J. Vis. Exp. 2010;6 doi: 10.3791/2511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2511</ArticleId><ArticleId IdType="pmc">PMC3159644</ArticleId><ArticleId IdType="pubmed">21189469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall A., Moghimi S. Determination of Polycation-Mediated Perturbation of Mitochondrial Respiration in Intact Cells by High-Resolution Respirometry (Oxygraph-2k, OROBOROS) Methods Mol. Biol. 2019;1943:313&#x2013;322. doi: 10.1007/978-1-4939-9092-4_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9092-4_20</ArticleId><ArticleId IdType="pubmed">30838625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Llewellyn K.J., Gomez A., Walker N., Su H., Dunnigan A., Chwa M., Vesa J., Kenney M.C., Kimonis V.E. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics. Mitochondrion. 2015;22:1&#x2013;8. doi: 10.1016/j.mito.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2015.02.004</ArticleId><ArticleId IdType="pmc">PMC7105354</ArticleId><ArticleId IdType="pubmed">25724235</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Steyn F.J., Stout M.B., Lee K., Cully T.R., Calder&#xf3;n J.C., Ngo S.T. Development of a high-throughput method for real-time assessment of cellular metabolism in intact long skeletal muscle fibre bundles. J. Physiol. 2016;594:7197&#x2013;7213. doi: 10.1113/JP272988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP272988</ArticleId><ArticleId IdType="pmc">PMC5157063</ArticleId><ArticleId IdType="pubmed">27619319</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson K., Allen S.P., Mortiboys H., Grierson A.J., Wharton S.B., Ince P.G., Shaw P.J., Heath P.R. The Effect of SOD1 Mutation on Cellular Bioenergetic Profile and Viability in Response to Oxidative Stress and Influence of Mutation-Type. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0068256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068256</ArticleId><ArticleId IdType="pmc">PMC3695905</ArticleId><ArticleId IdType="pubmed">23840839</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Duffy L.M., Shaw P.J., Grierson A.J. Neurobiology of Aging Altered age-related changes in bioenergetic properties and mitochondrial morphology in fi broblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2015;36:2893&#x2013;2903. doi: 10.1016/j.neurobiolaging.2015.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.07.013</ArticleId><ArticleId IdType="pubmed">26344876</ArticleId></ArticleIdList></Reference><Reference><Citation>Veys K., Alvarado-Diaz A., De Bock K. Measuring Glycolytic and Mitochondrial Fluxes in Endothelial Cells Using Radioactive Tracers. Methods Mol. Biol. 2019;1862:121&#x2013;136. doi: 10.1007/978-1-4939-8769-6_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8769-6_9</ArticleId><ArticleId IdType="pubmed">30315464</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumezbeur F., Petersen K.F., Cline G.W., Mason G.F., Behar K.L., Shulman G.I., Rothman D.L. The Contribution of Blood Lactate to Brain Energy Metabolism in Humans Measured by Dynamic 13C Nuclear Magnetic Resonance Spectroscopy. J. Neurosci. 2010;30:13983&#x2013;13991. doi: 10.1523/JNEUROSCI.2040-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2040-10.2010</ArticleId><ArticleId IdType="pmc">PMC2996729</ArticleId><ArticleId IdType="pubmed">20962220</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hall G., Str&#xf8;mstad M., Rasmussen P., Jans &#xd8;., Zaar M., Gam C., Quistorff B., Secher N.H., Nielsen H.B. Blood lactate is an important energy source for the human brain. J. Cereb. Blood Flow Metab. 2009;29:1121&#x2013;1129. doi: 10.1038/jcbfm.2009.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.35</ArticleId><ArticleId IdType="pubmed">19337275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Rene F., de Aguilar J.L.G., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101:11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D., Feunang Y.D., Marcu A., Guo A.C., Liang K., V&#xe1;zquez-Fresno R., Sajed T., Johnson D., Li C., Karu N., et al. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 2018;46:608&#x2013;617. doi: 10.1093/nar/gkx1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1089</ArticleId><ArticleId IdType="pmc">PMC5753273</ArticleId><ArticleId IdType="pubmed">29140435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramautar R., Nevedomskaya E., Mayboroda O.A., Deelder M., Wilson I.D., Gika H.G., Theodoridis G., Somsen G.W., de Jong G.J. Metabolic profiling of human urine by CE-MS using a positively charged capillary coating and comparison with UPLC-MS. Mol. Biosyst. 2011;7:194&#x2013;199. doi: 10.1039/C0MB00032A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C0MB00032A</ArticleId><ArticleId IdType="pubmed">21052608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanu A.B., Dwivedi P., Tam M., Matz L., Hill H.H.J. Ion mobility&#x2013;mass spectrometry. J. Mass Sepctrom. 2008;43:1&#x2013;22. doi: 10.1002/jms.1383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.1383</ArticleId><ArticleId IdType="pubmed">18200615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Xiao J.F., Tuli L., Ressom H.W. LC-MS-based metabolomics. Mol. Biosyst. 2012;8:470&#x2013;481. doi: 10.1039/C1MB05350G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C1MB05350G</ArticleId><ArticleId IdType="pmc">PMC3699692</ArticleId><ArticleId IdType="pubmed">22041788</ArticleId></ArticleIdList></Reference><Reference><Citation>Cajka T., Fiehn O. Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. Anal. Chem. 2016;88:524&#x2013;545. doi: 10.1021/acs.analchem.5b04491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.5b04491</ArticleId><ArticleId IdType="pubmed">26637011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowda G.A.N., Djukovic D. Overview of Mass Spectrometry-Based Metabolomics: Opportunities and Challenges. Methods Mol. Biol. 2014;1198:3&#x2013;12. doi: 10.1007/978-1-4939-1258-2_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-1258-2_1</ArticleId><ArticleId IdType="pmc">PMC4336784</ArticleId><ArticleId IdType="pubmed">25270919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes A.S., Cruz E.C.S., Sussulini A., Klassen A. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography. Adv. Exp. Med. Biol. 2017;965:77&#x2013;98. doi: 10.1007/978-3-319-47656-8_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-47656-8_4</ArticleId><ArticleId IdType="pubmed">28132177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Aller M., Gurny R., Veuthey J.L., Guillarme D. Coupling ultra high-pressure liquid chromatography with mass spectrometry: Constraints and possible applications. J. Chromatogr. A. 2013;1292:2&#x2013;18. doi: 10.1016/j.chroma.2012.09.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2012.09.061</ArticleId><ArticleId IdType="pubmed">23062879</ArticleId></ArticleIdList></Reference><Reference><Citation>March R. Quadrupole ion traps. Mass Spectrom. Rev. 2009;28:961&#x2013;989. doi: 10.1002/mas.20250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mas.20250</ArticleId><ArticleId IdType="pubmed">19492348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopley C., Bristow T., Lubben A., Simpson A., Bull E., Klagkou K., Herniman J., Langley J. Towards a universal product ion mass spectral library&#x2013;reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun. Mass Spectrom. 2008;22:1779&#x2013;1786. doi: 10.1002/rcm.3545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.3545</ArticleId><ArticleId IdType="pubmed">18470872</ArticleId></ArticleIdList></Reference><Reference><Citation>Denisov E.V., Damoc E., Lange O., Makarov A. Orbitrap Mass Spectrometry with Resolving Powers Above 1,000,000. Int. J. Mass Spectrom. 2012;325:80&#x2013;85. doi: 10.1016/j.ijms.2012.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijms.2012.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Edison A.S., Markley J.L., Bru R., Eghbalnia H.R., Powers R., Raftery D., Wishart D.S. The future of NMR-based metabolomics. Curr. Opin. Biotechnol. 2017;43:34&#x2013;40. doi: 10.1016/j.copbio.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2016.08.001</ArticleId><ArticleId IdType="pmc">PMC5305426</ArticleId><ArticleId IdType="pubmed">27580257</ArticleId></ArticleIdList></Reference><Reference><Citation>Emwas A., Roy R., Mckay R.T., Tenori L., Saccenti E., Gowda G.A.N., Raftery D., Alahmari F., Jaremko L., Jaremko M., et al. NMR Spectroscopy for Metabolomics Research. Metabolites. 2019;9:123. doi: 10.3390/metabo9070123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9070123</ArticleId><ArticleId IdType="pmc">PMC6680826</ArticleId><ArticleId IdType="pubmed">31252628</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena G.N., Rizzardini M., Cimini S., Siskos A.P., Bendotti C., Cantoni L., Keun H.C. Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2016;53:2222&#x2013;2240. doi: 10.1007/s12035-015-9165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9165-7</ArticleId><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex C., Corcia P., Piver E., Devos D., Dangoumau A., Gouel F., Vourc&#x2019;h P., Emond P., Laumonnier F., Nadal-Desbarats L., et al. Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2016;53:6910&#x2013;6924. doi: 10.1007/s12035-015-9567-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9567-6</ArticleId><ArticleId IdType="pubmed">26666663</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Patin F., Descat A., Garcon G., Corcia P., Gel&#xe9; P., Lenglet T., Bede P., Meininger V., Devos D., et al. A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLoS ONE. 2018;13 doi: 10.1371/journal.pone.0198116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198116</ArticleId><ArticleId IdType="pmc">PMC5988280</ArticleId><ArticleId IdType="pubmed">29870556</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Nadal-desbarats L., Pradat P.F., Gordon P.H., Antar C., Veyrat-durebex C., Moreau C., Devos D., Mavel S., Emond P., et al. Untargeted 1H-NMR metabolomics in CSF Toward a diagnostic biomarker for motor neuron disease. Neurology. 2014;82:1167&#x2013;1174. doi: 10.1212/WNL.0000000000000274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000274</ArticleId><ArticleId IdType="pubmed">24587475</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K., Zhang Z., O&#x2019;Reilly E.J., Berry J.D., Clish C.B., Deik A., Jeanfavre S., Kato I., Kelly R.S., Kolonel L.N., et al. Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology. 2019;92 doi: 10.1212/WNL.0000000000007401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007401</ArticleId><ArticleId IdType="pmc">PMC6512888</ArticleId><ArticleId IdType="pubmed">30926684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E., Larkin J.R., Claridge T.I.M.D.W., Talbot K., Sibson N.R., Turner M.R. The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2015;16:456&#x2013;463. doi: 10.3109/21678421.2015.1053490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1053490</ArticleId><ArticleId IdType="pmc">PMC4720042</ArticleId><ArticleId IdType="pubmed">26121274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A., Jonsson P., Ahnlund M., Antti H., Marklund S.L., Moritz T., Forsgren L., Andersen P.M., Trupp M. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson&#x2019;s. Mol. Biosyst. 2016;12:1287&#x2013;1298. doi: 10.1039/C5MB00711A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00711A</ArticleId><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinnick K.E., Gunn P.J., Hodson L. Measuring Human Lipid Metabolism Using Deuterium Labeling: In Vivo and In Vitro Protocols. Methods Mol. Biol. 2019;1862:83&#x2013;96. doi: 10.1007/978-1-4939-8769-6_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8769-6_6</ArticleId><ArticleId IdType="pubmed">30315461</ArticleId></ArticleIdList></Reference><Reference><Citation>Buescher J.M., Antoniewicz M.R., Boros L.G., Burgess S.C. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr. Med. Chem. 2015;34:189&#x2013;201. doi: 10.1016/j.copbio.2015.02.003.A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2015.02.003.A</ArticleId><ArticleId IdType="pmc">PMC4552607</ArticleId><ArticleId IdType="pubmed">25731751</ArticleId></ArticleIdList></Reference><Reference><Citation>El-maghrabey M., Kishikawa N., Kuroda N. Novel Isotope-Coded Derivatization Method for Aldehydes Using 14N/15N-Ammonium Acetate and 9,10-Phenanthrenequinone. Anal. Chem. 2018;90:13867&#x2013;13875. doi: 10.1021/acs.analchem.8b02458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.8b02458</ArticleId><ArticleId IdType="pubmed">30408416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiechert W. 13C Metabolic Flux Analysis. Curr. Opin. Biotechnol. 2001;3:206. doi: 10.1006/mben.2001.0187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mben.2001.0187</ArticleId><ArticleId IdType="pubmed">11461141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Labuschagne C.F., Vousden K.H., Maddocks O.D.K. Direct Estimation of Metabolic Flux by Heavy Isotope Labeling Simultaneous with Pathway Inhibition: Metabolic Flux Inhibition Assay. Methods Mol. Biol. 2019;1862:109&#x2013;119. doi: 10.1007/978-1-4939-8769-6_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8769-6_8</ArticleId><ArticleId IdType="pubmed">30315463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedl T.J., Gil R.S., Cheng F., Rayner S.L., Davidson J.M., De Luca A., Villalva M.D., Ecroyd H., Walker A.K., Lee A. Proteomics approaches for biomarker and drug target discovery in als and ftd. Front. Neurosci. 2019;13:548. doi: 10.3389/fnins.2019.00548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00548</ArticleId><ArticleId IdType="pmc">PMC6579929</ArticleId><ArticleId IdType="pubmed">31244593</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer E.B., Fallini C., Gozal Y.M., Duong D.M., Rossoll W., Xu P., Lah J.J., Levey A.I., Peng J., Bassell G.J., et al. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS ONE. 2012;7 doi: 10.1371/journal.pone.0038658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038658</ArticleId><ArticleId IdType="pmc">PMC3380899</ArticleId><ArticleId IdType="pubmed">22761693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ling S.C., Qiu J., Albuquerque C.P., Zhou Y., Tokunaga S., Li H., Qiu H., Bui A., Yeo G.W., et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat Commun. 2015;6:6171. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra B.B. New Tools and Resources in Metabolomics: 2016&#x2013;2017. Electrophoresis. 2018;39:909&#x2013;923. doi: 10.1002/elps.201700441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.201700441</ArticleId><ArticleId IdType="pubmed">29292835</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitropoulos M., Vasilopoulou C., Maga-Nteve C., Klapa M. Untargeted GC-MS Metabolomics. Methods Mol. Biol. 2018;1738:133&#x2013;147. doi: 10.1007/978-1-4939-7643-0_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7643-0_9</ArticleId><ArticleId IdType="pubmed">29654587</ArticleId></ArticleIdList></Reference><Reference><Citation>Want E.J., Maille G.O., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., Trauger S.A., Siuzdak G. Solvent-dependent Metabolite Distribution, Clustering, and Protein Extraction for Serum Profiling with Mass Spectrometry. Anal. Chem. 2006;78:743&#x2013;752. doi: 10.1021/ac051312t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac051312t</ArticleId><ArticleId IdType="pubmed">16448047</ArticleId></ArticleIdList></Reference><Reference><Citation>Venable J.D., Dong M., Wohlschlegel J., Dillin A., Iii J.R.Y. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods. 2004;1:1&#x2013;7. doi: 10.1038/nmeth705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth705</ArticleId><ArticleId IdType="pubmed">15782151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Yan R. Improved Data-Dependent Acquisition for Untargeted Metabolomics Using Gas-Phase Fractionation with Staggered Mass Range. Anal. Chem. 2015;5:2861&#x2013;2868. doi: 10.1021/ac504325x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac504325x</ArticleId><ArticleId IdType="pubmed">25654645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugawa H., Cajka T., Kind T., Ma Y., Higgins B., Ikeda K., Kanazawa M., VanderGheynst J., Fiehn O., Arita M. MS-DIAL: Data Independent MS/MS Deconvolution for Comprehensive Metabolome Analysis. Nat. Methods. 2015;12:523&#x2013;526. doi: 10.1038/nmeth.3393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3393</ArticleId><ArticleId IdType="pmc">PMC4449330</ArticleId><ArticleId IdType="pubmed">25938372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiehn O. Metabolomics by Gas Chromatography-Mass Spectrometry: The combination of targeted and untargeted profiling. Curr. Opin. Biotechnol. 2017;114:30&#x2013;34. doi: 10.1002/0471142727.mb3004s114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb3004s114</ArticleId><ArticleId IdType="pmc">PMC4829120</ArticleId><ArticleId IdType="pubmed">27038389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Lu H., Hou Y. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass Spectrom. Rev. 2018;37:772&#x2013;792. doi: 10.1002/mas.21562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mas.21562</ArticleId><ArticleId IdType="pubmed">29486047</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenn L.S., Mclean J.A. Structural resolution of carbohydrate positional and structural isomers based on gas-phase ion mobility-mass spectrometry. Phys. Chem. Chem. Phys. 2011;13:2196&#x2013;2205. doi: 10.1039/C0CP01414A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C0CP01414A</ArticleId><ArticleId IdType="pubmed">21113554</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;ala M., L&#xed;sa M., Campbell J.L., Hol&#x10d;apek M. Determination of triacylglycerol regioisomers using differential mobility spectrometry. Rapid Commun. Mass Spectrom. 2016;30:256&#x2013;264. doi: 10.1002/rcm.7430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.7430</ArticleId><ArticleId IdType="pubmed">27071217</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Corcia P., Pradat P.F., Bocca C., Gordon P.H., Veyrat-durebex C., Mavel S., Nadal-Desbarats L., Moreau C., Devos D., et al. Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry. J. Protome Res. 2013;12:3746&#x2013;3754. doi: 10.1021/pr400376e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400376e</ArticleId><ArticleId IdType="pubmed">23859630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Qi B., Lv H., Wu F., Liu L., Wang W., Wang Q., Hu L., Hao Y., Wang Y. A new method of isolating spinal motor neurons from fetal mouse. J. Neurosci. Methods. 2017;288:57&#x2013;61. doi: 10.1016/j.jneumeth.2017.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2017.06.014</ArticleId><ArticleId IdType="pubmed">28648716</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber D.J., Harris B.T. Purification and Culture of Spinal Motor Neurons from Rat Embryos. Cold Spring Harb. Protoc. 2013;2013:319&#x2013;327. doi: 10.1101/pdb.prot074161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot074161</ArticleId><ArticleId IdType="pubmed">23547162</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S., Medinas D.B., Hetz C. Common ground: Stem cell approaches find shared pathways underlying ALS. Cell Stem. Cell. 2014;14:697&#x2013;699. doi: 10.1016/j.stem.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.05.001</ArticleId><ArticleId IdType="pubmed">24905158</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Velde C.V., Cleveland D.W.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien J., Robitaille R., Arbour D., Tremblay E. Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model. J. Neurosci. 2015;35:688&#x2013;706. doi: 10.1523/JNEUROSCI.1379-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Gutmann D.H., Roos R.P. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 2011;20:286&#x2013;293. doi: 10.1093/hmg/ddq463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq463</ArticleId><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Oussini H.E.L., Mersmann S., Drenner K., Wagner M., Sun Y., Allmeroth K., Dieterl&#xe9; S., Sinniger J., Dirrig-Grosch S., et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS - associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Morrison B.M., Li Y., Lengacher S., Farah M.H., Hoffman P.N., Liu Y., Tsingalia A., Jin L., Zhang P.W., et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., De Aguilar J.G., Echaniz-laguna A., Eschbach J. Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons. PLoS ONE. 2009;4 doi: 10.1371/journal.pone.0005390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Castelli L.M., Francis L., Woof R., Siskos A.P., Kouloura E., Gray E., Thompson A.G., Talbot K., et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain. 2019;142:586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Woof R., Francis L., Gatto N., Shaw A.C., Myszczynska M., Hemingway J., Coldicott I., Willcock A., et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 2019 doi: 10.1093/brain/awz302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz302</ArticleId><ArticleId IdType="pmc">PMC6906594</ArticleId><ArticleId IdType="pubmed">31647549</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F., Maduro C., Fisher E.M.C., Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12 doi: 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.037424</ArticleId><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Broekaert D.F.S. Measuring In Vivo Tissue Metabolism Using 13C Glucose Infusions in Mice. Methods Mol. Biol. 2019;1862:67&#x2013;82. doi: 10.1007/978-1-4939-8769-6_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8769-6_5</ArticleId><ArticleId IdType="pubmed">30315460</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro M.M. Zebrafish as a model to explore cell metabolism. Trends Endocrinol. Metab. 2014;25:546&#x2013;554. doi: 10.1016/j.tem.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2014.06.003</ArticleId><ArticleId IdType="pubmed">24997878</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti L., Gh A., Rottoli E., Maglie M., De Prosperi L., Perego C., Baruscotti M., Bucchi A., Del Giacco L., Francolini M. INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model. Sci. Rep. 2016;6:24515. doi: 10.1038/srep24515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24515</ArticleId><ArticleId IdType="pmc">PMC4832213</ArticleId><ArticleId IdType="pubmed">27079797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Lattante S., Le Ber I., Latouche M., Tostivint H., Brice A., Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa M.M.J., Allen C.E., Higginbottom A., Ramesh T., Shaw P.J., Mcdermott C.J. A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Dis. Model. Mech. 2014;7:73&#x2013;81. doi: 10.1242/dmm.012013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.012013</ArticleId><ArticleId IdType="pmc">PMC3882050</ArticleId><ArticleId IdType="pubmed">24092880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcgown A., Mcdearmid J.R., Panagiotaki N., Tong H., Mashhadi S., Al Redhead N., Lyon A.N., Beattie C.E., Shaw P.J., Ramesh T.M. Early Interneuron Dysfunction in ALS: Insights from a Mutant sod1 Zebrafish Model. Ann. Neurol. 2012;73:246&#x2013;258. doi: 10.1002/ana.23780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23780</ArticleId><ArticleId IdType="pmc">PMC3608830</ArticleId><ArticleId IdType="pubmed">23281025</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulus J.D., Link B.A. Loss of Optineurin In Vivo Results in Elevated Cell Death and Alters Axonal Trafficking Dynamics. PLoS ONE. 2014;9 doi: 10.1371/journal.pone.0109922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109922</ArticleId><ArticleId IdType="pmc">PMC4199637</ArticleId><ArticleId IdType="pubmed">25329564</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid B., Hruscha A., Hogl S., Banzhaf-strathmann J., Strecker K. Loss of ALS-associated TDP-43 in zebra fish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc. Natl. Acad. Sci. USA. 2013;110:4986&#x2013;4991. doi: 10.1073/pnas.1218311110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218311110</ArticleId><ArticleId IdType="pmc">PMC3612625</ArticleId><ArticleId IdType="pubmed">23457265</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan A., Bouffard M., Liao M., Ryan S., Callister J.B., Pickering-brown S.M., Armstrong G.A.B., Drapeau P. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model. Hum. Mol. Genet. 2018;27:1754&#x2013;1762. doi: 10.1093/hmg/ddy083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy083</ArticleId><ArticleId IdType="pmc">PMC5932562</ArticleId><ArticleId IdType="pubmed">29528390</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten S.A., Armstrong G.A.B., Lissouba A., Kabashi E., Parker J.A., Drapeau P. Fishing for causes and cures of motor neuron disorders. Dis. Model. Mech. 2014;7:799&#x2013;809. doi: 10.1242/dmm.015719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId><ArticleId IdType="pmc">PMC4073270</ArticleId><ArticleId IdType="pubmed">24973750</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs E.M., Horstick E.J., Dowling J.J. Swimming into prominence: The zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. FEBS J. 2014;280:4187&#x2013;4197. doi: 10.1111/febs.12412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12412</ArticleId><ArticleId IdType="pmc">PMC4017590</ArticleId><ArticleId IdType="pubmed">23809187</ArticleId></ArticleIdList></Reference><Reference><Citation>Babin P.J., Goizet C., Raldu D. Zebrafish models of human motor neuron diseases: Advantages and limitations. Prog. Neurobiol. 2014;118:36&#x2013;58. doi: 10.1016/j.pneurobio.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2014.03.001</ArticleId><ArticleId IdType="pubmed">24705136</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Model. Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Xu F., Lam S., Gong Z., Ong C. Metabolomics of developing zebrafish embryos using gas chromatography- and liquid chromatography-mass spectrometry. Mol. Biosyst. 2013;9:1372&#x2013;1380. doi: 10.1039/c3mb25450j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3mb25450j</ArticleId><ArticleId IdType="pubmed">23475132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu J., Gong Z., Kelly B.C. Metabolomic Profiling of Zebrafish (Danio rerio) Embryos Exposed to the Antibacterial Agent Triclosan. Environ. Toxic. Chem. 2019;38:240&#x2013;249. doi: 10.1002/etc.4292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/etc.4292</ArticleId><ArticleId IdType="pubmed">30325051</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello J., Derks R.J.E., Lopes S.S., Steenvoorden E. Zebrafish Larvae Are a Suitable Model to Investigate the Metabolic Phenotype of Drug-Induced Renal Tubular Injury. Front. Pharmacol. 2018;9:1&#x2013;9. doi: 10.3389/fphar.2018.01193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.01193</ArticleId><ArticleId IdType="pmc">PMC6232664</ArticleId><ArticleId IdType="pubmed">30459607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhu W., Wang D., Teng M., Yan J., Miao J., Zhou Z. 1H NMR-based metabolomics analysis of adult zebrafish (Danio rerio) after exposure to diniconazole as well as its bioaccumulation behavior. Chemosphere. 2017;168:1571&#x2013;1577. doi: 10.1016/j.chemosphere.2016.11.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2016.11.157</ArticleId><ArticleId IdType="pubmed">27938984</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy U., Conklin L., Schiller J., Matysik J., Berry J.P., Alia A. Metabolic profiling of zebrafish (Danio rerio) embryos by NMR spectroscopy reveals multifaceted toxicity of &#x3b2; -methylamino-L-alanine (BMAA) Sci. Rep. 2017;7:17305. doi: 10.1038/s41598-017-17409-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17409-8</ArticleId><ArticleId IdType="pmc">PMC5725574</ArticleId><ArticleId IdType="pubmed">29230019</ArticleId></ArticleIdList></Reference><Reference><Citation>Blattmann P., Stutz V., Lizzo G., Richard J., Gut P. Data Descriptor: Generation of a zebra fi sh SWATH-MS spectral library to quantify 10,000 proteins. Nat. Publ. Gr. 2019;6:190011. doi: 10.1038/sdata.2019.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2019.11</ArticleId><ArticleId IdType="pmc">PMC6371892</ArticleId><ArticleId IdType="pubmed">30747917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino C.C., Roman B.L., Drummond I.A., Hukriede N.A. Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury Part 1: Microinjections. J. Vis. Exp. 2010;4:2079. doi: 10.3791/2079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/2079</ArticleId><ArticleId IdType="pmc">PMC3156013</ArticleId><ArticleId IdType="pubmed">20729805</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khourv A.E., Fukagawa N.K., Sanchez M., Tsay R.H., Gleason R.E., Chapman T.E., Young V.R. Validation of the tracer-balance concept with reference to leucine: 24-h intravenous tracer studies with L-[1-13C]leucine and [15N-15N]urea. Am. J. Clin. Nutr. 1994;59:1000&#x2013;1011. doi: 10.1093/ajcn/59.5.1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/59.5.1000</ArticleId><ArticleId IdType="pubmed">8172083</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker S., Kortz L., Helmschrodt C., Thiery J., Ceglarek U. LC&#x2013;MS-based metabolomics in the clinical laboratory. J. Chromatogr. B. 2012;883:68&#x2013;75. doi: 10.1016/j.jchromb.2011.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2011.10.018</ArticleId><ArticleId IdType="pubmed">22074957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T., Nishiumi S., Ikeda A., Yoshie T., Sakai A., Matsubara A. A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer. Cancer Epidemiol. Prev. Biomark. 2013;242:571&#x2013;580. doi: 10.1158/1055-9965.EPI-12-1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-12-1033</ArticleId><ArticleId IdType="pubmed">23542803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobard E., Pontoizeau C., Blaise B.J., Bachelot T., Elena-herrmann B., Tr&#xe9;dan O. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Lett. 2014;343:33&#x2013;41. doi: 10.1016/j.canlet.2013.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2013.09.011</ArticleId><ArticleId IdType="pubmed">24041867</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited ALS. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Proia P., Maria C., Liegro D., Schiera G., Fricano A., Di Liegro I. Lactate as a Metabolite and a Regulator in the Central Nervous System. Int. J. Mol. Sci. 2016;17:1450. doi: 10.3390/ijms17091450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17091450</ArticleId><ArticleId IdType="pmc">PMC5037729</ArticleId><ArticleId IdType="pubmed">27598136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungai-sal&#xe1;nki R., Gerecsei T., F&#xfc;rjes P., Orgovan N., S&#xe1;ndor N., Holczer E., Horvath R., Szab&#xf3; B. Automated single cell isolation from suspension with computer vision. Sci. Rep. 2016;6:20375. doi: 10.1038/srep20375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20375</ArticleId><ArticleId IdType="pmc">PMC4746594</ArticleId><ArticleId IdType="pubmed">26856740</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakadan S.M., Shalek A.K., Weitz D.A. Scaling by shrinking: Empowering single-cell &#x201c;omics&#x201d; with microfluidic devices. Nat. Rev. Genet. 2017;18:345&#x2013;361. doi: 10.1038/nrg.2017.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.15</ArticleId><ArticleId IdType="pmc">PMC5495114</ArticleId><ArticleId IdType="pubmed">28392571</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A.J., Hill A.S., Love J.C. Nanowell-Based Immunoassays for Measuring Single-Cell Secretion: Characterization of Transport and Surface Binding. Anal. Chem. 2014;86:11562&#x2013;11569. doi: 10.1021/ac4030297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac4030297</ArticleId><ArticleId IdType="pmc">PMC4255675</ArticleId><ArticleId IdType="pubmed">25347613</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger M.A., Chou H., Thorsen T., Scherer A., Quake S.R. Monolithic Microfabricated Valves and Pumps by Multilayer Soft Lithography. Science. 2000;288:113&#x2013;116. doi: 10.1126/science.288.5463.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5463.113</ArticleId><ArticleId IdType="pubmed">10753110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yobas Y.L., Levent L. Microfluidic emulsification through a monolithic integrated glass micronozzle suspended inside a flow-focusing geometry. Appl. Phys. Lett. 2015;106:174101. doi: 10.1063/1.4919444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.4919444</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo D., Wu L.Y., Lee L.P. Dynamic single cell culture array. Lab. Chip. 2006;6:1445&#x2013;1449. doi: 10.1039/b605937f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b605937f</ArticleId><ArticleId IdType="pubmed">17066168</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara S., Amer S., Ali A., Abouleila Y., April Oga A., Tsutomu Masujima T. Single-Cell Metabolomics. Adv. Exp. Med. Biol. 2017;965:323&#x2013;343. doi: 10.1007/978-3-319-47656-8_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-47656-8_13</ArticleId><ArticleId IdType="pubmed">28132186</ArticleId></ArticleIdList></Reference><Reference><Citation>Laiko V.V., Baldwin M.A., Burlingame A.L. Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry. Anal. Chem. 2000;72:652&#x2013;657. doi: 10.1021/ac990998k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac990998k</ArticleId><ArticleId IdType="pubmed">10701247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejedor M.L., Mizuno H., Tsuyama N., Harada T., Masujima T. Direct Single-Cell Molecular Analysis of Plant Tissues by Video Mass Spectrometry. Anal. Sci. 2009;25:1053&#x2013;1055. doi: 10.2116/analsci.25.1053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2116/analsci.25.1053</ArticleId><ArticleId IdType="pubmed">19745529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaganman I. SIMS for membranes. Nat. Methods. 2006;3:962&#x2013;963. doi: 10.1038/nmeth1206-962a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth1206-962a</ArticleId><ArticleId IdType="pubmed">17190006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher J.S., Kotze H.L., Armitage E.G., Lockyer N.P., Vickerman JCFletcher J.S., Kotze H.L., Armitage E.G., Lockyer N.P., Vickerman J.C. Evaluating the challenges associated with time-of-fight secondary ion mass spectrometry for metabolomics using pure and mixed metabolites. Metabolomics. 2013;9:535&#x2013;544. doi: 10.1007/s11306-012-0487-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-012-0487-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft M.L., Klitzing H.A. Biochimica et Biophysica Acta Imaging lipids with secondary ion mass spectrometry. BBA Mol. Cell Biol. Lipids. 2014;1841:1108&#x2013;1119. doi: 10.1016/j.bbalip.2014.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2014.03.003</ArticleId><ArticleId IdType="pubmed">24657337</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha B., Vertes A. In Situ Metabolic Profiling of Single Cells by Laser Ablation Electrospray Ionization Mass. Anal. Chem. 2009;81:8265&#x2013;8271. doi: 10.1021/ac901525g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac901525g</ArticleId><ArticleId IdType="pubmed">19824712</ArticleId></ArticleIdList></Reference><Reference><Citation>An S., Kumar R., Sheets E.D., Benkovic S.J. Reversible Compartmentalization of de Novo Purine Biosynthetic Complexes in Living Cells. Science. 2008;320:103&#x2013;106. doi: 10.1126/science.1152241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1152241</ArticleId><ArticleId IdType="pubmed">18388293</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanella M.E., Chu H., Low P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl. Acad. Sci. USA. 2005;107:2402&#x2013;2407. doi: 10.1073/pnas.0409741102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409741102</ArticleId><ArticleId IdType="pmc">PMC549020</ArticleId><ArticleId IdType="pubmed">15701694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecchin A., Stapor P.C., Goveia J., Carmeliet P. Metabolic pathway compartmentalization: An underappreciated opportunity? Curr. Opin. Biotechnol. 2014;34:73&#x2013;81. doi: 10.1016/j.copbio.2014.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2014.11.022</ArticleId><ArticleId IdType="pubmed">25499800</ArticleId></ArticleIdList></Reference><Reference><Citation>Spivey H.O., Ovadi J. Substrate Channeling. Methods. 1999;19:306&#x2013;321. doi: 10.1006/meth.1999.0858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.1999.0858</ArticleId><ArticleId IdType="pubmed">10527733</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-durebex C., Bris C., Codron P., Bocca C., Chupin S., Corcia P., Vourc&#x2019;h P., Hergesheimer R., Cassereau J., Funalot B., et al. Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms. Mol. Neurobiol. 2019;56:5780&#x2013;5791. doi: 10.1007/s12035-019-1484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1484-7</ArticleId><ArticleId IdType="pubmed">30680691</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin S., Klimcakova E., St-pierre J. Free Radical Biology &amp; Medicine Impact of PGC-1 &#x3b1; on the topology and rate of superoxide production by the mitochondrial electron transport chain. Free Radic. Biol. Med. 2011;51:2243&#x2013;2248. doi: 10.1016/j.freeradbiomed.2011.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.08.036</ArticleId><ArticleId IdType="pubmed">21964033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel S., Andrzejewski S., Avizonis D., St-pierre J. Stable Isotope Tracer Analysis in Isolated Mitochondria from Mammalian Systems. Metabolites. 2014;4:166&#x2013;183. doi: 10.3390/metabo4020166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo4020166</ArticleId><ArticleId IdType="pmc">PMC4101501</ArticleId><ArticleId IdType="pubmed">24957021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamer O., Gravel S., Choiniere L., Chenard V., St-pierre J., Avizonis D. The complete targeted profile of the organic acid intermediates of the citric acid cycle using a single stable isotope dilution analysis, sodium borodeuteride reduction and selected ion monitoring GC/MS. Metabolomics. 2013;9:1019&#x2013;1030. doi: 10.1007/s11306-013-0521-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-013-0521-1</ArticleId><ArticleId IdType="pmc">PMC3855487</ArticleId><ArticleId IdType="pubmed">24348278</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonnenmacher Y., Palorini R., Hiller K. Determining Compartment-Specific Metabolic Fluxes. Methods Mol. Biol. 2019;1862:137&#x2013;149. doi: 10.1007/978-1-4939-8769-6_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8769-6_10</ArticleId><ArticleId IdType="pubmed">30315465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zala D., Hinckelmann M., Yu H., Menezes M., Marco S., Cordelie F.P. Vesicular Glycolysis Provides On-Board Energy for Fast Axonal Transport. Cell. 2013;152:479&#x2013;491. doi: 10.1016/j.cell.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.029</ArticleId><ArticleId IdType="pubmed">23374344</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahen V.A., Cantrill L.C., Bahram N. A simple and efficient toolset for analysing mitochondrial tra ffi cking in neuronal cells. Acta Histochem. 2018;120:797&#x2013;805. doi: 10.1016/j.acthis.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acthis.2018.09.001</ArticleId><ArticleId IdType="pubmed">30224246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Li Y., Yang M., Chen X., Chen Y., Yang F., Lu S., Yao S., Zhou T., Liu J., et al. A new method for quantifying mitochondrial axonal transport. Protein Cell. 2016;7:804&#x2013;819. doi: 10.1007/s13238-016-0268-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-016-0268-3</ArticleId><ArticleId IdType="pmc">PMC5084152</ArticleId><ArticleId IdType="pubmed">27225265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol. 2002;48:155&#x2013;171. doi: 10.1023/A:1013713905833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1013713905833</ArticleId><ArticleId IdType="pubmed">11860207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Haasdijk E.D., Grashorn J.A.C., Hawkins R., Van Duijn W., Verspaget H.W., London J., Holstege J.C. Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1. Neurobiol. Dis. 2000;643:623&#x2013;643. doi: 10.1006/nbdi.2000.0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Wang P., Chen X., Cheng H., Liu J., Fushimi K. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc. Natl. Acad. Sci. USA. 2018;115:9678&#x2013;9686. doi: 10.1073/pnas.1806655115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806655115</ArticleId><ArticleId IdType="pmc">PMC6187197</ArticleId><ArticleId IdType="pubmed">30249657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J., Mitra S., Tomkinson A.E., Van Den Bosch L., Hegde M.L. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj B.T., Livesey M.R., Zhao C., Gregory J.M., James O.T., Cleary E.M., Chouhan A.K., Gane A.B., Perkins E.M., Dando O., et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity. Nat. Commun. 2018;9:347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T., Uzel S.G.M., Kamm R.D. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci. Adv. 2018;4:5847. doi: 10.1126/sciadv.aat5847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aat5847</ArticleId><ArticleId IdType="pmc">PMC6179377</ArticleId><ArticleId IdType="pubmed">30324134</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T., Sivathanu V., Kamm R.D. Engineered 3D vascular and neuronal networks in a microfluidic platform. Sci. Rep. 2018;8:5168. doi: 10.1038/s41598-018-23512-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23512-1</ArticleId><ArticleId IdType="pmc">PMC5979969</ArticleId><ArticleId IdType="pubmed">29581463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113 doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S., Bruijn L., Chandran S., Eggan K., Ho R., Klim J., Livesey M.R., Lowry E., Macklis J.D., Rushton D., et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 2016;19:542&#x2013;553. doi: 10.1038/nn.4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M., Sharma A., Lyashchenko A.K., Shneider N.A. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc. Natl. Acad. Sci. USA. 2016;113 doi: 10.1073/pnas.1605210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk S.E., Tracey T.J., Steyn F.J., Ngo S.T. Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Front. Neurol. 2019;10 doi: 10.3389/fneur.2019.00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00191</ArticleId><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Santibanez R., Burford M., Bucelli R.C. Hereditary Motor Neuropathies and Amyotrophic Lateral Sclerosis: A Molecular and Clinical Update. Curr. Neurol. Neurosci. Rep. 2018;18:93. doi: 10.1007/s11910-018-0901-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-018-0901-z</ArticleId><ArticleId IdType="pubmed">30328519</ArticleId></ArticleIdList></Reference><Reference><Citation>Akimoto M., Nakamura K. Edaravone for treatment of early-stage ALS&#x2013;Authors&#x2019; reply. Lancet Neurol. 2017;16:772. doi: 10.1016/S1474-4422(17)30290-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30290-9</ArticleId><ArticleId IdType="pubmed">28920878</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan K.S., Halang L., Woods I., Prehn J.H.M. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43 A315T mutant C57BL6/J mice. Dis. Model. Mech. 2016;9:1029&#x2013;1037. doi: 10.1242/dmm.024786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.024786</ArticleId><ArticleId IdType="pmc">PMC5047697</ArticleId><ArticleId IdType="pubmed">27491077</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Murthy S.B., Wilson A.M., Qureshi S.U., Moath J., Wheaton M., Simpson E., Harati Y., Strutt A.M., York M.K., et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS A decrease in body mass index is associated with faster progression. Amyotroph. Lateral Scler. 2010;11:542&#x2013;548. doi: 10.3109/17482968.2010.482592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.482592</ArticleId><ArticleId IdType="pubmed">20500116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E., Dupuis L., M&#xfc;ller H.P., Neumann H., Ludolph A.C., Kassubek J. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.J., Ju T.C., Chen H.M., Jang Y.S., Lee L.M., Lai H.L., Tai H.C., Fang J.M., Lin Y.L., Tu P.H., et al. Activation of AMP-activated protein kinase a1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2015;24:787&#x2013;801. doi: 10.1093/hmg/ddu497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu497</ArticleId><ArticleId IdType="pubmed">25256353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Zhang K., Sandoval H., Yamamoto S., Jaiswal M., Sanz E., Li Z., Hui J., Graham B.H., Quintana A., et al. Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration. Cell. 2015;160:177&#x2013;190. doi: 10.1016/j.cell.2014.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.12.019</ArticleId><ArticleId IdType="pmc">PMC4377295</ArticleId><ArticleId IdType="pubmed">25594180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrdlickova R., Toloue M., Tian B., Genetics M., New R. RNA-Seq methods for transcriptome analysis. Wiley Interdiscip Rev. RNA. 2017;8:1&#x2013;24. doi: 10.1002/wrna.1364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1364</ArticleId><ArticleId IdType="pmc">PMC5717752</ArticleId><ArticleId IdType="pubmed">27198714</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinderwala F., Lonergan S., Woods J., Zhou C., Fey P.D., Powers R. Expanding the Coverage of the Metabolome with Nitrogen-Based NMR. Anal. Chem. 2018;90:4521&#x2013;4528. doi: 10.1021/acs.analchem.7b04922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.7b04922</ArticleId><ArticleId IdType="pmc">PMC6472702</ArticleId><ArticleId IdType="pubmed">29505241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>